StonvexLoading…
StonvexStonvexStonvexCore line items from TRMK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $214.53M | $232.07M | $948.62M | $709.29M | $466.57M |
Operating Income | Not available | $68.00M | $274.68M | $203.94M | $134.19M |
Net Income | Not available | $56.12M | $224.13M | $166.26M | $55.84M |
EPS (Diluted) | $0.98 | $0.95 | $3.70 | $2.74 | $1.80 |
Total Assets | Not available | $18.99B | $18.93B | $18.80B | $18.62B |
Total Liabilities | Not available | $16.86B | $16.80B | $16.69B | $16.54B |
Cash & Equivalents | Not available | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | $20.62M | $231.95M | $177.83M | $115.14M |
Shares Outstanding | Not available | 58.68M | 59.01M | 60.13M | 60.40M |